The reality is that paper is more of a habit than a requirement. AstraZeneca discovered this when they aimed to introduce ELNs to improve the efficiency of their validated workflows for GMP API manufacture.
Trio’s lead compound TML-2 is the acetyl prodrug of TML-1, a novel, well tolerated G-protein coupled receptor antagonist which shows clinical promise but has limited bioavailability owing to low solubility. Trio turned to Catalent for help.
Zydis® fast dissolve formulation for Zelapar® (Selegiline anti-Parkinson’s compound) had a positive impact on the patient compliance as compared to the Selegiline traditional tablets.
A Q&A session with formulation and bioavailability experts on addressing formulation challenges for pediatric populations.
Thoughtful lateral flow assay design and development is key to high performance and minimized costs, achieved in part by selecting the best components for optimal assay results.
By checking the pulse of your organization, you can identify gaps and develop a plan for how to address them, so you can make the right decisions at the right time.
A commercial stage medical technology company has developed SMART Softgels featuring a special shell to release quickly while still preventing evaporative loss during and after manufacturing.
Discover how new smart valve technology can automate your pneumatic energy savings, tamper proof your equipment settings, and enable flexible automation.
TÜV Rheinland, a testing and certification leader at the forefront of interoperability, performance and safety in the globally connected world, today announced its Littleton, MA lab has been accepted to operate in the IECEE CB Scheme (IEC System of Conformity Assessment Schemes for Electrotechnical Equipment and Components) under the responsibility of National Certification Body (NCB) TUV Rheinland of North America, Inc. Approval was obtained for the medical and electrical product safety lab in Littleton, MA, for the Product Categories and subsequent standards as listed on the IECEE website